| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 127.89B | 131.94B | 131.29B | 161.71B | 134.55B | 136.18B |
| Gross Profit | 7.47B | 7.57B | 7.34B | 8.26B | 7.67B | 7.65B |
| EBITDA | 5.42B | 5.50B | 5.18B | 5.50B | 4.33B | 3.82B |
| Net Income | -2.86B | -2.51B | 1.02B | 637.00M | 1.57B | -96.00M |
Balance Sheet | ||||||
| Total Assets | 72.28B | 73.63B | 79.02B | 84.78B | 73.37B | 67.36B |
| Cash, Cash Equivalents and Short-Term Investments | 11.82B | 11.56B | 10.27B | 9.75B | 7.93B | 9.17B |
| Total Debt | 33.00B | 31.75B | 35.83B | 38.23B | 26.70B | 19.20B |
| Total Liabilities | 57.18B | 58.30B | 59.30B | 66.77B | 56.28B | 52.43B |
| Stockholders Equity | 15.07B | 15.29B | 19.70B | 18.00B | 17.03B | 14.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.87B | 4.71B | -2.64B | -5.95B | 892.00M |
| Operating Cash Flow | 0.00 | 10.35B | 8.66B | 361.00M | -3.51B | 2.59B |
| Investing Cash Flow | 0.00 | -3.65B | -4.74B | -8.76B | -2.09B | -1.95B |
| Financing Cash Flow | 0.00 | -5.57B | -3.45B | 10.14B | 6.09B | 4.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥411.76B | 9.21 | 11.96% | 3.04% | 2.70% | ― | |
78 Outperform | ¥679.46B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥6.47T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
70 Outperform | ¥79.68B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
67 Neutral | ¥3.88T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
65 Neutral | ¥8.60B | 7.87 | -14.16% | 2.98% | -5.25% | -281.76% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |